Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

Life expectancy in hereditary cancer predisposing diseases: an observational study.

Wilding A, Ingham SL, Lalloo F, Clancy T, Huson SM, Moran A, Evans DG.

J Med Genet. 2012 Apr;49(4):264-9. doi: 10.1136/jmedgenet-2011-100562. Epub 2012 Feb 23.

PMID:
22362873
2.

Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service.

Evans DG, Howard E, Giblin C, Clancy T, Spencer H, Huson SM, Lalloo F.

Am J Med Genet A. 2010 Feb;152A(2):327-32. doi: 10.1002/ajmg.a.33139.

PMID:
20082463
3.

Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989.

Evans DG, O'Hara C, Wilding A, Ingham SL, Howard E, Dawson J, Moran A, Scott-Kitching V, Holt F, Huson SM.

Eur J Hum Genet. 2011 Nov;19(11):1187-91. doi: 10.1038/ejhg.2011.113. Epub 2011 Jun 22. Erratum in: Eur J Hum Genet. 2013 Sep;21(9):1031.

4.

Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.

Kley N, Whaley J, Seizinger BR.

Glia. 1995 Nov;15(3):297-307. Review.

PMID:
8586465
5.

A genetic register for von Hippel-Lindau disease.

Maddock IR, Moran A, Maher ER, Teare MD, Norman A, Payne SJ, Whitehouse R, Dodd C, Lavin M, Hartley N, Super M, Evans DG.

J Med Genet. 1996 Feb;33(2):120-7.

6.

Malignant peripheral nerve sheath tumours in NF1: improved survival in women and in recent years.

Ingham S, Huson SM, Moran A, Wylie J, Leahy M, Evans DG.

Eur J Cancer. 2011 Dec;47(18):2723-8. doi: 10.1016/j.ejca.2011.05.031. Epub 2011 Jun 21.

PMID:
21700447
7.

Reduced life expectancy seen in hereditary diseases which predispose to early-onset tumors.

Evans DG, Ingham SL.

Appl Clin Genet. 2013 Jul 24;6:53-61. doi: 10.2147/TACG.S35605. Print 2013.

9.

The impact of molecular genetic analysis of the VHL gene in patients with haemangioblastomas of the central nervous system.

Gläsker S, Bender BU, Apel TW, Natt E, van Velthoven V, Scheremet R, Zentner J, Neumann HP.

J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):758-62.

10.
11.

Genetic and epigenetic alterations in the von hippel-lindau gene: the influence on renal cancer prognosis.

Smits KM, Schouten LJ, van Dijk BA, Hulsbergen-van de Kaa CA, Wouters KA, Oosterwijk E, van Engeland M, van den Brandt PA.

Clin Cancer Res. 2008 Feb 1;14(3):782-7. doi: 10.1158/1078-0432.CCR-07-1753.

12.

[Neurofibromatosis: the most frequent hereditary tumor predisposition syndrome].

Wimmer K.

Wien Med Wochenschr. 2005 Jun;155(11-12):273-80. German.

PMID:
16035388
13.

Impact of screening examinations on survival in familial adenomatous polyposis.

Heiskanen I, Luostarinen T, Järvinen HJ.

Scand J Gastroenterol. 2000 Dec;35(12):1284-7.

PMID:
11199368
14.

The global impact of noncommunicable diseases: estimates and projections.

Manton KG.

World Health Stat Q. 1988;41(3-4):255-66.

PMID:
3232413
15.

The risk of malignant tumours in first-degree relatives of men with early onset prostate cancer: a population-based cohort study.

Bratt O, Kristoffersson U, Lundgren R, Olsson H.

Eur J Cancer. 1997 Nov;33(13):2237-40.

PMID:
9470812
16.

The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.

Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.

Int J Mol Med. 2007 Oct;20(4):605-11.

PMID:
17786294
17.

Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia.

Viscomi S, Pastore G, Dama E, Zuccolo L, Pearce N, Merletti F, Magnani C.

Ann Oncol. 2006 Jan;17(1):167-71. Epub 2005 Oct 25.

18.

Mosaicism in sporadic neurofibromatosis type 1: variations on a theme common to other hereditary cancer syndromes?

Kehrer-Sawatzki H, Cooper DN.

J Med Genet. 2008 Oct;45(10):622-31. doi: 10.1136/jmg.2008.059329. Epub 2008 May 29. Review.

PMID:
18511569
19.

Surgical management for advanced duodenal adenomatosis and duodenal cancer in Dutch patients with familial adenomatous polyposis: a nationwide retrospective cohort study.

van Heumen BW, Nieuwenhuis MH, van Goor H, Mathus-Vliegen LE, Dekker E, Gouma DJ, Dees J, van Eijck CH, Vasen HF, Nagengast FM.

Surgery. 2012 May;151(5):681-90. doi: 10.1016/j.surg.2011.12.008. Epub 2012 Jan 21.

PMID:
22265391
20.

Malignant peripheral nerve sheath tumours in neurofibromatosis 1.

Evans DG, Baser ME, McGaughran J, Sharif S, Howard E, Moran A.

J Med Genet. 2002 May;39(5):311-4.

Items per page

Supplemental Content

Write to the Help Desk